"In addition, these results highlight the need for further research to elucidate potential mechanistic links between GLP-1 receptor agonist therapy, weight loss, and hair loss, and to identify patient level risk factors that may increase susceptibility to hair loss." It's worth pointing out that the medical records the researchers were dealing with were limited in terms of measuring the severity and duration of the hair loss, and whether or not it was reversible
Individuals with cerebral folate deficiency have been observed to have developmental delays with autistic features (e.g., challenges with social communication, sensory processing, and repetitive behaviors), seizures, and problems with movement and coordination
Without validated biomarkers of efficacy, real-world results remain anecdotal at best
A personalized treatment plan should weigh your BMI, comorbidities, insurance status, and goal weight rather than defaulting to whichever drug is cheapest